|
HESI: Human Health and Safety |
|
Enduring |
|
$0.00 |
|
HESI Human health and Safety |
|
Enduring |
|
$0.00 |
|
Regulatory guidance: Introduction |
|
Enduring |
|
$25.00 |
|
Systems biology applied to immune safety |
|
Enduring |
|
$25.00 |
|
T cell targeting therapies (e.g. activation, inhibition pathways, therapies, toxicities) |
|
Enduring |
|
$25.00 |
|
Basic principles of toxicology, toxicology of the immune system, relevance to immunosafety |
|
Enduring |
|
$25.00 |
|
Immunogenicity characterization tools (ADAs, complement, immune complexes) |
|
Enduring |
|
$25.00 |
|
B cell targeting therapies (e.g. activation, inhibition pathways, therapies, toxicities) |
|
Enduring |
|
$25.00 |
|
Definition, history and application of immunosafety in drug development |
|
Enduring |
|
$25.00 |
|
Immunopathology: evaluation, assessment, and considerations |
|
Enduring |
|
$25.00 |
|
Innate immune cell therapies (e.g. activation, inhibition pathways, therapies, toxicities) |
|
Enduring |
|
$25.00 |
|
Basic Immunology: Introduction to Immune Cells and Innate and Adaptive Immunity |
|
Enduring |
|
$25.00 |
|
Assessing adversity in immunosafety (preclinical) |
|
Enduring |
|
$25.00 |
|
Immunopathology: evaluation, assessment, and considerations |
|
Enduring |
|
$25.00 |
|
Safety assessment outside of drug development (e.g. agrichemicals, cosmetics, food additives, etc.) |
|
Enduring |
|
$25.00 |
Facebook
Twitter
LinkedIn
Forward